Machatha Stephen 4
4 · Aldeyra Therapeutics, Inc. · Filed Mar 2, 2023
Insider Transaction Report
Form 4
Machatha Stephen
Chief Development Officer
Transactions
- Award
Stock Option (right to buy)
2023-02-28+220,258→ 220,258 totalExercise: $6.76Exp: 2033-02-27→ Common Stock (220,258 underlying)
Footnotes (1)
- [F1]The shares subject to this option shall vest in equal monthly installments over the next 48 months of continuous service to the Issuer after January 1, 2023.